Incretin-based therapies and a potential drug interaction.
G M
GM
Gabb
W
W
Smith
D000799:Angioedema / Q000201:enzymology / Q000209:etiology / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D001920:Bradykinin / Q000037:antagonists & inhibitors / Q000378:metabolism; D048909:Diabetes Complications / Q000188:drug therapy; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D054795:Incretins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D054795:Incretins; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4; D001920:Bradykinin